Inventor
Yurong XIN
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C12NMicroorganisms or enzymes22%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms16%
C12YEnzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,359,20117ss-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof202512,286,677Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation202511,845,963HSD17B13 variants and uses thereof202311,753,628HSD17B13 variants and uses thereof202311,702,700Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation202311,485,958HSD17B13 variants and uses thereof202211,180,75717b-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to REGENERON PHARMA (7)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 7 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |